- Cyberman
- Posts
- 🚨 Musk vs OpenAI: $500B Stargate clash
🚨 Musk vs OpenAI: $500B Stargate clash
+ AI-designed drugs are coming
Greetings! Your latest quick tech update is here:
☀️ On this day: On January 24, 2006, Walt Disney announced its acquisition of Pixar Animation Studios for $7.4 billion. The deal solidified Disney's leadership in animation and brought iconic Pixar films under its umbrella.
What’s happening:
🚨 Musk vs. OpenAI: $500B Stargate clash
💊 AI-designed drugs to hit trials by 2026
🤖 OpenAI unveils Operator: AI that works for you
🧠 DeepSeek's free AI model challenges OpenAI
🛑 LinkedIn sued for using private messages in AI training
+ 📊 Daily poll and results
+ 📈 Trending tools and resources
Together with Rundown
Start learning AI in 2025
Everyone talks about AI, but no one has the time to learn it. So, we found the easiest way to learn AI in as little time as possible: The Rundown AI.
It's a free AI newsletter that keeps you up-to-date on the latest AI news, and teaches you how to apply it in just 5 minutes a day.
Plus, complete the quiz after signing up and they’ll recommend the best AI tools, guides, and courses – tailored to your needs.
Hand-picked news:
🚨 Musk vs. OpenAI: $500B Stargate clash ↗️LINK
What: Elon Musk questioned the funding behind the $500 billion Stargate AI project, announced by Donald Trump alongside leaders from OpenAI, Oracle, and Softbank. Musk claimed Softbank lacks sufficient funds, sparking rebuttals from OpenAI CEO Sam Altman and others involved.
Why: Musk’s critique highlights his strained relationship with Altman and skepticism over the project’s financial viability. The initiative aims to bolster U.S. AI infrastructure, creating 100,000 jobs and involving major investments from OpenAI, Oracle, and others.
Impact: Musk's comments cast doubt on the project’s credibility but underscore the stakes in the U.S. AI race. Despite the controversy, shares of Oracle rose 7%, signaling investor optimism about AI infrastructure expansion.
💊 AI-designed drugs to hit trials by 2026 ↗️LINK
What: Alphabet's Isomorphic Labs, using DeepMind’s AI technology like AlphaFold, plans to have AI-designed drugs in clinical trials by the end of 2026. Collaborations with Eli Lilly and Novartis focus on treating diseases like cancer, cardiovascular issues, and neurodegeneration.
Why: AI's ability to model complex protein structures accelerates drug discovery, addressing urgent health needs such as developing new antibiotics and therapies for untreatable diseases. Other AI firms, like Insilico Medicine, have already shown success in trials for pulmonary fibrosis and inflammatory bowel disease.
Impact: AI-driven breakthroughs promise faster, cost-effective drug development, reshaping healthcare. If successful, these advancements could address unmet medical needs, reduce research timelines, and broaden access to innovative treatments globally.
🤖 OpenAI unveils Operator: AI that works for you ↗️LINK
What: OpenAI launched "Operator," an AI agent capable of performing tasks like booking travel, shopping online, and navigating websites autonomously. Initially available in the U.S. on ChatGPT’s $200 Pro plan, Operator uses its own web browser powered by OpenAI’s advanced Computer-Using Agent (CUA) model.
Why: Operator automates routine tasks, integrating AI into daily life more deeply than tools like Siri or Alexa. OpenAI collaborates with major companies like DoorDash and Uber to ensure compatibility and maintain compliance with site terms.
Impact: Operator represents a leap forward in AI agents, potentially redefining internet usage. However, with limitations like supervision for sensitive tasks and rate caps, its full potential is yet to be realized. Safeguards address risks, but user trust will be key.
🧠 DeepSeek's free AI model challenges OpenAI ↗️LINK
What: DeepSeek unveiled its R1 AI model family, including a 671-billion-parameter version, under an open MIT license. The model reportedly rivals OpenAI's o1 reasoning model on benchmarks like AIME and MATH-500, offering advanced reasoning capabilities at no cost.
Why: R1's release is significant as it democratizes cutting-edge AI, with smaller versions that run on local devices. Open-source access enables broad adoption and customization, challenging proprietary models' dominance.
Impact: This development could accelerate global AI innovation but raises concerns over censorship, as cloud-hosted R1 adheres to Chinese content regulations. Locally run versions, however, bypass these restrictions, ensuring accessible advanced reasoning capabilities worldwide.
🛑 LinkedIn sued for using private messages in AI training ↗️LINK
What: LinkedIn faces a class-action lawsuit alleging it shared Premium users’ private messages with third parties to train AI models without consent. The lawsuit accuses LinkedIn of breaching contracts, violating the Stored Communications Act (SCA), and engaging in unlawful practices under California law.
Why: The lawsuit claims LinkedIn enabled data-sharing by default in 2024 and retroactively amended privacy policies, violating user trust. Plaintiffs seek damages and deletion of AI models trained using improperly shared data.
Impact: This case highlights growing concerns over data privacy in AI training and casts scrutiny on Microsoft products linked to LinkedIn. It underscores potential legal and reputational risks for companies using customer data without transparent consent.
Today’s Poll:
Are you optimistic about AI finding cures for diseases like cancer and neurodegeneration? |
Vote and find out about the result tomorrow.
Yesterday’s Poll Result:
Do you think creating 100,000 jobs justifies the $500B investment?
A) Yes – Job creation is a strong incentive - 37%
B) No – Other industries could create more sustainable jobs - 63% 🏆
Full Machine Learning Course (free): This Learning Plan is designed to help Data Scientists and Developers integrate machine learning (ML) and artificial intelligence (AI) into tools and applications.
Prompt Engineering Repository: Covers the history, strategies, guidelines, and safety recommendations for working with LLMs.
ElevenLabs: The ElevenLabs voice generator can deliver high-quality, human-like speech in 32 languages. Perfect for audiobooks, video voiceovers, commercials, and more.
Gamma: Create unlimited presentations, websites, and more—in seconds. Everything you need to quickly create and refine content with advanced AI.
Hey there! Quick ask 🙋♂️
If this email landed in your 'Promotions' or 'Spam' folder, could you move it to your Primary Inbox?
I work hard to deliver top news, tips, and tutorials to save you time. But if these emails get lost in the shuffle, we both miss out.
By moving it to your Primary Inbox, you’ll never miss a beat on the latest updates. Let’s stay in the loop and keep growing together! 🚀